ClinicalTrials.gg
CompletedNCT01770847Updated Nov 17, 2017

Arterial Stiffness in Chronic Kidney Disease

An observational study in Chronic Kidney Disease, sponsored by University of Edinburgh. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 79 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-11-17.

Sponsored by University of Edinburgh · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
50
Ages
18 Years to 79 Years
Sex
All
01

Study summary

Diurnal variations in the cardiovascular system apparent in healthy individuals, are different in chronic kidney disease patients. Therefore, diurnal variations in arterial stiffness may also differ in chronic kidney disease patients. This study aims to identify and evaluate diurnal variations in arterial stiffness in chronic kidney disease patients and compare them to those in age matched healthy controls.

02

Conditions studied

  • Chronic Kidney Disease
03

In context

Renal Insufficiency, Chronic

3,224 studies on the registry are indexed under Renal Insufficiency, Chronic; 706 are open to participants now.

This study's planned enrollment of 50 is below the median of 200 across 889 observational studies indexed under Renal Insufficiency, Chronic.

Browse Renal Insufficiency, Chronic studies →

Lead sponsor

University of Edinburgh is the lead sponsor of 403 studies on the registry; 65 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Potential patients will be identified from renal clinics at the Royal Infirmary and Western General Hospital. Suitable participants will initially be identified by a member of the direct healthcare team.

Healthy volunteers will be indentified through the Clinical Research Centre community database and poster advertising at the University of Edinburgh.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Systolic blood pressure \<160 whether or not on antihypertensive medication
  • diastolic blood pressure \<100mmHg whether or not on antihypertensive medication
  • Chronic kidney disease stage 2-5

Exclusion criteria

Exclusion Criteria:

  • Systolic blood pressure ≥160mmHg
  • Diastolic blood pressure ≥100mmhg
  • Significant comorbidity (investigator opinion but to include alcoholism and terminal illness)
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Healthy controls

    Healthy age matched controls

  • Chronic kidney diease

    Chronic kidney disease patients stage 2-4

06

What researchers measure

Primary outcomes

  1. Diurnal variations in arterial stiffness

    The principal objective of this study is to evaluate whether diurnal variations in arterial stiffness are blunted in chronic kidney disease compared to healthy age matched controls

    Time frame: Over one 26 hour period arterial stiffness measurements will be obtained every 30 minutes from 7am to 12am and every 60 minutes from 12am to 7am

Secondary outcomes

  1. Diurnal variations in aortic and brachial blood pressure

    Secondary objective of this study is to evaluate whether diurnal variations in aortic and brachial blood pressure are blunted in chronic kidney disease compared to healthy age matched controls

    Time frame: Over one 26 hour period blood pressure measurements will be obtained every 30 minutes from 7am to 12am and every 60 minutes from 12am to 7am

  2. Relationship between changes in blood pressure and arterial stiffness

    Secondary objective of this study is to evaluate whether diurnal variations in arterial stiffness are dependent on changes in blood pressure in both chronic kidney disease patients and age matched controls.

    Time frame: Over one 26 hour period

07

Study locations

1 site
  • Clinical Research Centre, 2nd Floor Western General Hospital
    Edinburgh, EH4 2XU, United Kingdom
08

References and documents

Publications

  • Dhaun N, Moorhouse R, MacIntyre IM, Melville V, Oosthuyzen W, Kimmitt RA, Brown KE, Kennedy ED, Goddard J, Webb DJ. Diurnal variation in blood pressure and arterial stiffness in chronic kidney disease: the role of endothelin-1. Hypertension. 2014 Aug;64(2):296-304. doi: 10.1161/HYPERTENSIONAHA.114.03533. PubMed 24890823 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2012 and a primary completion of Dec 2013. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 28, 2012
First posted
Jan 18, 2013
Start
Nov 2012
Primary completionActual
Dec 2013
Last update
Nov 17, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 17, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01770847
Responsible party
Sponsor
First posted
Jan 18, 2013
Start date
Nov 2012
Primary completion
Dec 2013
Last update
Nov 17, 2017

Study contacts

David J Webb, MB BS MD DSc FRCP FRSE FMedSci
principal investigator · University of Edinburgh

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion